August 2017 – Advanced enzymes acquires 100% stake in evoxx technologies

Advanced Enzyme Technologies Limited (Advanced Enzymes; NSE: ADVENZYMES; BSE: 540025), a leading speciality biotech company, with global leadership in the manufacturing of enzymes, today announced that its wholly owned subsidiary Advanced Enzymes Europe B.V. has entered into a binding agreement with Germany based Evoxx Technologies GmbH, to acquire a 100% stake for a consideration of € 7.65 million.

V.L. Rathi, Chairman, Advanced Enzymes, said, “Evoxx has a great strategic fit for us. With

Evoxx we significantly expand our R&D capabilities, and also strengthen our European presence.”

Evoxx Technologies GmbH is an industrial biotech company focused on the development & production of industrial enzymes, as well as a few specialized carbohydrates for nutritional applications. Evoxx was founded as evocatal GmbH in 2006, and has a team of 35+ scientists & technicians across two sites in Germany.

Click to View PDF

Request a call back